NICE (UK) positive for Beyonttra (acoramidis) for treating transthyretin amyloidosis with cardiomyopathy – Bayer

NICE(UK): Acoramidis can be used, within its marketing authorisation, as an option to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults.

Acoramidis can only be used if the company provides it according to the commercial arrangement.